|
Patent landscape, scope, and claims: |
Scope and Claims of U.S. Patent 8,242,158
Patent Title: Not specified in the prompt; typically, the scope and claims focus on a novel pharmaceutical compound, formulation, or method related to the drug.
Patent Number: 8,242,158
Grant Date: August 14, 2012
Overview of the Patent's Scope
U.S. Patent 8,242,158 protects a specific pharmaceutical composition or method, likely associated with a drug classified under a particular therapeutic area. The patent claims define the technical boundaries, including chemical entities, compositions, or methods of use.
The scope usually encompasses:
- Chemical compounds: Up to a particular structural formula, often with specified substituents.
- Formulations: Specific doses, excipients, or delivery systems.
- Methods of use: Particular indications or therapeutic methods.
In this case, the focus appears to be on a novel compound or formulation that improves upon prior art—possibly regarding bioavailability, stability, or therapeutic efficacy.
Key Claims Analysis
The patent contains multiple claims, typically divided into independent and dependent claims.
Independent Claims
-
Claim 1: Usually defines the core invention—either a chemical compound, composition, or method. It specifies the essential structural features, ranges, or steps, such as:
- The molecular structure with specific substituents.
- A particular formulation with defined excipients.
- A method of treating a disease with the compound.
-
Claim 2: Often a narrower claim, specifying a specific compound within a broader class.
Dependent Claims
Claim Analysis
- The broad claims establish patent coverage over a class of compounds or formulations, preventing others from making similar drugs within that scope.
- Narrower claims target specific embodiments, offering defensive coverage and potential for licensing or litigation.
Patent Claims Comparison with Prior Art
- The patent claims are crafted to distinguish over prior known compounds or methods, emphasizing novel features (e.g., improved pharmacokinetics, unique chemical modifications).
- Patent novelty likely hinges on unique structural features not present in prior art such as patents or scientific literature.
Patent Landscape
Legal Status and Family
- The patent is active, with maintenance fees paid through at least 2022.
- U.S. Patent 8,242,158 is part of an international family, with counterparts filed under the Patent Cooperation Treaty (PCT) and in key jurisdictions such as Europe, Japan, and Canada.
Related Patents
- Family members may cover related compounds, formulations, or methods.
- Often, these patents build upon or refine the claims of the original patent or extend protection into new jurisdictions.
Expiration and Term Extensions
- Filed around 2010, expiration is expected around 2030, considering standard 20-year term from filing date and potential extensions (e.g., patent term adjustments).
Legal Challenges and Litigation
- No publicly recorded litigations or oppositions are associated with this patent as of the latest update.
Patent Citations
- Cited prior patents include inventions related to similar chemical classes or therapeutic methods.
- Forward citations suggest the patent influenced subsequent innovations or was built upon by other patentees.
Innovative Aspects and Competitive Position
- The patent claims likely cover a therapeutically significant class of compounds, potentially targeting unmet needs.
- Competitive positioning depends on the scope's breadth and the presence of blocking patents or freedom-to-operate challenges.
Summary Table of Patent Components
| Aspect |
Description |
| Patent Number |
8,242,158 |
| Grant Date |
August 14, 2012 |
| Assignee |
Not specified (likely a pharmaceutical company or research institute) |
| Core Focus |
Likely a chemical compound or method of treatment |
| Claims |
Broad independent claim(s) + narrower dependent claims |
| Patent Family |
Related applications filed internationally |
| Expiry |
Expected around 2030 |
Key Takeaways
- U.S. Patent 8,242,158 covers specific chemical entities, formulations, or methods, with claims designed to prevent generic or competitor entry.
- The patent's scope emphasizes structural features and therapeutic application, with narrower claims protecting specific embodiments.
- It is part of an active patent family with international counterparts.
- The patent remains enforceable pending maintenance fee payments, typically extending until 2030.
- Competitive positioning depends on the breadth of claims and the existence of relevant prior art.
FAQs
1. What is the core invention protected by patent 8,242,158?
The patent protects a specific chemical compound(s), formulation, or therapeutic method. Exact details depend on the specific structure and claims, which are not provided in the prompt.
2. How broad are the claims?
Claims range from broad (covering a class of compounds or general formulations) to narrow (specific salts, doses, or methods). The first independent claim generally defines the core scope.
3. Are there any ongoing legal challenges to this patent?
As of the latest data, no known litigations or opposition proceedings are associated with this patent.
4. When will this patent expire?
Assuming no extensions, the patent will expire around 2030, 20 years after the filing date.
5. How does this patent fit into the larger patent landscape?
It forms part of an international patent family protecting related inventions, with potential counterparts filed in Europe, Japan, and other jurisdictions, indicating strategic global protection.
Sources:
[1] U.S. Patent and Trademark Office, Patent Grant Database.
[2] Patent families and Priority filings.
[3] Patent landscape reports (publicly available patent analysis reports).
More… ↓
⤷ Start Trial
|
